Skip to main content

A phase II trial of letrozole and trastuzumab for ER and/or PgR and HER2 positive metastatic breast cancer: Final results.

Publication ,  Conference
Marcom, PK; Isaacs, C; Harris, L; Bryant, M; Kommareddy, A; Tao, Y; Mann, G; Ellis, MJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

27S / 27S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marcom, P. K., Isaacs, C., Harris, L., Bryant, M., Kommareddy, A., Tao, Y., … Ellis, M. J. (2005). A phase II trial of letrozole and trastuzumab for ER and/or PgR and HER2 positive metastatic breast cancer: Final results. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 27S-27S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Marcom, P. K., C. Isaacs, L. Harris, M. Bryant, A. Kommareddy, Y. Tao, G. Mann, and M. J. Ellis. “A phase II trial of letrozole and trastuzumab for ER and/or PgR and HER2 positive metastatic breast cancer: Final results.” In JOURNAL OF CLINICAL ONCOLOGY, 23:27S-27S. AMER SOC CLINICAL ONCOLOGY, 2005.
Marcom PK, Isaacs C, Harris L, Bryant M, Kommareddy A, Tao Y, et al. A phase II trial of letrozole and trastuzumab for ER and/or PgR and HER2 positive metastatic breast cancer: Final results. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 27S-27S.
Marcom, P. K., et al. “A phase II trial of letrozole and trastuzumab for ER and/or PgR and HER2 positive metastatic breast cancer: Final results.JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 27S-27S.
Marcom PK, Isaacs C, Harris L, Bryant M, Kommareddy A, Tao Y, Mann G, Ellis MJ. A phase II trial of letrozole and trastuzumab for ER and/or PgR and HER2 positive metastatic breast cancer: Final results. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 27S-27S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

27S / 27S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences